InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Venkatesan Jay, Directeur. Officer active across 5 companies, notably ALPINE IMMUNE SCIENCES, INC.. Aggregated, 11 disclosures have been logged. Breakdown: 5 buys · 1 sell. Total volume traded: €3.5m. History available since 17 September 2021. The latest transaction was disclosed on 31 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Venkatesan Jay is Director and has 11 filings in total. In the sampled recent filings, they cover the period from 2021-09-21 to 2026-04-21, with buys of EUR 292770 and sells of EUR 3195248, and the modal transaction nature is Acquisition. They are listed at Angion Biomedica Corp., Serina Therapeutics, Inc., Elicio Therapeutics, Inc., Alpine Immune Sciences, INC. and ALPINE IMMUNE SCIENCES, INC.